3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Completed
10
Terminated
3
Active not recruiting
3
Recruiting
2
Withdrawn
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Dermatologic
2
Sarcoma
1
Conditions
Prostatic Neoplasms
17
Glioblastoma
8
Esophageal Neoplasms
8
Squamous Cell Carcinoma of Head and Neck
7
Rectal Neoplasms
7
Oropharyngeal Neoplasms
7
Breast Neoplasms
7
Mouth Neoplasms
6
Glioma
6
Triple Negative Breast Neoplasms
4
Lung Neoplasms
4
Laryngeal Neoplasms
4
Head and Neck Neoplasms
4
Brain Neoplasms
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Stomach Neoplasms
3
Sarcoma
3
Pancreatic Neoplasms
3
Multiple Myeloma
3
Neuroblastoma
2
Neoplasms
2
Nasopharyngeal Carcinoma
2
Melanoma
2
Medulloblastoma
2
Hypopharyngeal Neoplasms
2
Ganglioneuroblastoma
2
Endometrial Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
pembrolizumab
54
Nivolumab
50
Ipilimumab
28
Cyclophosphamide
16
binimetinib
10
Specimen Handling
10
Magnetic Resonance Spectroscopy
10
fludarabine
9
Radiosurgery
9
relatlimab
8
encorafenib
8
Opdualag
8
Biopsy
8
aldesleukin
7
Interleukin-2
7
atezolizumab
6
Immunotherapy
6
Blood Specimen Collection
6
cemiplimab
5
CTLA-4 Antigen
5
Bevacizumab
5
trametinib
4
fludarabine phosphate
4
dabrafenib
4
Temozolomide
4
Paclitaxel
4
Immune Checkpoint Inhibitors
4
spartalizumab
3
Surgical Procedures, Operative
3
Metformin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Melanoma
×
Radiation
×
Clear all
NCT06889766
2026-05-15
LauT1
Centre Hospitalier Universitaire Vaudois
Phase 1
Recruiting
9 enrolled
NCT04594187
2026-02-17
MelPORT
M.D. Anderson Cancer Center
Phase 2
Recruiting
168 enrolled